Translation of Ischemic Preconditioning to the Patient
- 1 November 2004
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 35 (11_suppl_1), 2687-2689
- https://doi.org/10.1161/01.str.0000143216.85349.9e
Abstract
Effective therapies for stroke must interdict multiple parallel and sequential pathophysiological events. A paradigm which offers insight into multivalent but thoughtfully coordinated protective programs is ischemic preconditioning. A central hypothesis of our group and others is that pharmacological agents that activate programs of gene expression normally induced by ischemic preconditioning will be effective agents for the prevention and treatment of stroke. Inhibitors of a class of enzymes, the hypoxia inducible factor-1 (HIF-1) prolyl hydroxylases stabilize the transcriptional activator HIF-1 and activate target genes involved in compensation for ischemia, including erythropoeitin (Epo) and vascular endothelial growth factor (VEGF). Here, we review evidence suggesting that the HIF-1 prolyl hyroxylases are inhibited during ischemic preconditioning and that pharmacological inhibitors of these enzymes are viable targets for stroke therapy.Keywords
This publication has 26 references indexed in Scilit:
- Endogenous 2-oxoacids differentially regulate expression of oxygen sensorsBiochemical Journal, 2004
- Ischaemic preconditioning: therapeutic implications for stroke?Emerging Therapeutic Targets, 2004
- Transient Ischemic Attacks Before Ischemic Stroke: Preconditioning the Human Brain?Stroke, 2004
- Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant statesThe Lancet, 2003
- Ethanol Plus Caffeine (Caffeinol) for Treatment of Ischemic StrokeStroke, 2003
- New perspectives on developing acute stroke therapyAnnals of Neurology, 2002
- Oxygen sensors and angiogenesisSeminars in Cell & Developmental Biology, 2002
- C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl HydroxylationCell, 2001
- Synergistic Combinatorial Stroke Therapy: A Quantal Bioassay of a GABA Agonist and a Glutamate AntagonistExperimental Neurology, 2000
- Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal ratNeuroscience Letters, 1994